Takip et
Mohamed El-Tanani
Mohamed El-Tanani
Ras Al Khaima Medical and Health Sciences University (RAK)
rakmhsu.ac.ae üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer
PS Rudland, A Platt-Higgins, M El-Tanani, S de Silva Rudland, ...
Cancer research 62 (12), 3417-3427, 2002
4302002
Tuning in to RF MEMS
GM Rebeiz, K Entesari, IC Reines, SJ Park, MA El-Tanani, A Grichener, ...
IEEE microwave magazine 10 (6), 55-72, 2009
4092009
Two separate mechanisms for ligand-independent activation of the estrogen receptor
MKK El-Tanani, CD Green
Molecular Endocrinology 11 (7), 928-937, 1997
2421997
The regulation and role of osteopontin in malignant transformation and cancer
MK El-Tanani, FC Campbell, V Kurisetty, D Jin, M McCann, PS Rudland
Cytokine & growth factor reviews 17 (6), 463-474, 2006
2312006
Chemosensitization of cancer cells by siRNA using targeted nanogel delivery
EB Dickerson, WH Blackburn, MH Smith, LB Kapa, LA Lyon, JF McDonald
BMC cancer 10, 1-11, 2010
1602010
Ets gene PEA3 cooperates with β-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription
M El-Tanani, A Platt-Higgins, PS Rudland, FC Campbell
Journal of Biological Chemistry 279 (20), 20794-20806, 2004
1452004
The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control
FC Campbell, H Xu, M El-Tanani, P Crowe, V Bingham
Biochemical pharmacology 79 (1), 1-9, 2010
1412010
Corrugated microstrip coupled lines for constant absolute bandwidth tunable filters
MA El-Tanani, GM Rebeiz
IEEE Transactions on Microwave Theory and Techniques 58 (4), 956-963, 2010
1382010
High-performance 1.5–2.5-GHz RF-MEMS tunable filters for wireless applications
MA El-Tanani, GM Rebeiz
IEEE Transactions on Microwave Theory and Techniques 58 (6), 1629-1637, 2010
1352010
A flip-chip-packaged 25.3 dBm class-D outphasing power amplifier in 32 nm CMOS for WLAN application
H Xu, Y Palaskas, A Ravi, M Sajadieh, MA El-Tanani, K Soumyanath
IEEE Journal of Solid-State Circuits 46 (7), 1596-1605, 2011
1152011
A two-pole two-zero tunable filter with improved linearity
MA El-Tanani, GM Rebeiz
IEEE Transactions on Microwave Theory and Techniques 57 (4), 830-839, 2009
1132009
Role of osteopontin in cellular signaling and metastatic phenotype
MK El-Tanani
Front Biosci 13 (4), 276, 2008
1082008
Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways
HF Yuen, KK Chan, C Grills, JT Murray, A Platt-Higgins, OS Eldin, ...
Clinical Cancer Research 18 (2), 380-391, 2012
1072012
Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation
CK Mason, S McFarlane, PG Johnston, P Crowe, PJ Erwin, MM Domostoj, ...
Molecular cancer therapeutics 7 (3), 548-558, 2008
1062008
DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma
HF Yuen, YP Chan, S Law, G Srivastava, M El-Tanani, TW Mak, KW Chan
Cancer Epidemiology Biomarkers & Prevention 17 (12), 3593-3602, 2008
1012008
Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line
Z Shi, VM Hodges, EA Dunlop, MJ Percy, AP Maxwell, M El-Tanani, ...
Molecular Cancer Research 8 (4), 615-626, 2010
952010
Osteopontin as a target for cancer therapy
NI Johnston, VK Gunasekharan, A Ravindranath, C O’Connell, ...
Front Biosci 13 (4361), 72, 2008
912008
Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells
MKK El-Tanani, CD Green
The Journal of steroid biochemistry and molecular biology 60 (5-6), 269-276, 1997
851997
Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG
Y Haggag, Y Abdel-Wahab, O Ojo, M Osman, S El-Gizawy, M El-Tanani, ...
International journal of pharmaceutics 499 (1-2), 236-246, 2016
842016
RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin
VV Kurisetty, PG Johnston, N Johnston, P Erwin, P Crowe, DG Fernig, ...
Oncogene 27 (57), 7139-7149, 2008
822008
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20